Arca
Skip to content
Tools
Tools

Gablofen (baclofen injection)

Recall D-1742-2019, part of FDA recall event 83280. See Piramal Critical Care, Inc.'s company page.

Piramal Critical Care, Inc. started this Class II drug recall on Jul 8, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated Mar 9, 2021.

  • Classification: Class II
  • Started: Jul 8, 2019
  • Status: Terminated

Why It Was Recalled

Class II

Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.

Record

Product
Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe, Distributed by: Primal Critical Care, Inc., 3950 Schelden Circle Bethlehem, PA, 18017, NDC 66794-151-01
Quantity
Lot 2155-111 (1,418 boxes) and Lot 2155-111A (5,640 boxes)
Lots and codes
Lot #: 2155-111, 2155-111A, Exp 6/20
Distribution
USA Nationwide
Recalling firm
Piramal Critical Care, Inc., Bethlehem, PA, United States
How the firm notified
Letter
FDA classified
Aug 13, 2019

Piramal Critical Care, Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.